Folate‐appended cyclodextrin carrier targets ovarian cancer cells expressing the proton‐coupled folate transporter-Reference-Cited by-同舟云学术

Folate‐appended cyclodextrin carrier targets ovarian cancer cells expressing the proton‐coupled folate transporter

Published:2020-04-03 Issue:5 Volume:111 Page:1794-1804
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Saito Shinichi¹²^ORCID,Koya Yoshihiro¹²,Kajiyama Hiroaki³,Yamashita Mamoru²,Kikkawa Fumitaka³,Nawa Akihiro¹²

Affiliation:

1. Department of Obstetrics and Gynecology Collaborative Research Bell Research Center Nagoya University Graduate School of Medicine Nagoya Japan

2. Bell Research Center for Reproductive Health and Cancer Medical Corporation Kishokai Aichi Japan

3. Department of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14379

Reference47 articles.

1. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype

2. Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials

3. Current development in the formulations of non-injection administration of paclitaxel

4. Molecular inclusion complexes of β‐cyclodextrin derivatives enhance aqueous solubility and cellular internalization of paclitaxel: preformulation and in vitro assessments;Shah M;J Pharm Pharmacol (Los Angel),2015

5. Cyclodextrin–Drug Inclusion Complexes: In Vivo and In Vitro Approaches

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BBOX1 mediates metabolic reprogramming driven by hypoxia and participates in the malignant progress of high-grade serous ovarian cancer;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Folic acid modified precision nanocarriers: charting new frontiers in breast cancer management beyond conventional therapies;Journal of Drug Targeting;2024-05-22

3. Synthetic Receptors for Early Detection and Treatment of Cancer;Biosensors;2023-10-25

4. Lipid nanocarrier targeting activated macrophages for antiretroviral therapy of HIV reservoir;Nanomedicine;2023-08

5. Recent Progress of Supramolecular Chemotherapy Based on Host–Guest Interactions;Advanced Materials;2023-07-21